• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Merck tops Q1 earnings, revenue estimates

May 2, 2017 By Sarah Faulkner

MerckShares in Merck (NYSE:MRK) rose today after the company met expectations on Wall Street with its 1st quarter results.

The Kenilworth, N.J.-based company posted profits of $1.55 billion, or 56¢ per share, on sales of $9.43 billion for the 3 months ended March 31, for bottom-line growth of 18.3% on sales growth of 1.3% compared with the same period last year.

Adjusted to exclude 1-time items, earnings per share were 88¢, ahead of consensus on The Street, where analysts were looking for sales of $9.3 billion.

“Merck delivered solid performance across our broad range of products that address major disease categories and the needs of global health,” chairman & CEO Kenneth Frazier said in prepared remarks. “The continued momentum of Keytruda in oncology, along with the strength of the vaccine and other franchises and animal health, helped to drive revenue growth in the quarter.”

Merck said it expects to post adjusted earnings in the range of $3.76 to $3.88 on sales of $39.1 billion to $40.3 billion, an increase from earlier figures, for the full year of 2017.

MRK shares were trading at $62.55 apiece today in mid-morning trading, up 0.3%.

Filed Under: Featured, MassDevice Earnings Roundup, Pharmaceuticals, Wall Street Beat Tagged With: Merck

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS